The Rise of “Pharma 4.0” in Brazil
As of early 2026, Brazil has solidified its position as the largest pharmaceutical market in Latin America. Industry data highlights a “transition from defensive to offensive” strategies, where local companies are using AI and digital health tools as core infrastructure for drug discovery and supply chain management to navigate a high-stakes, rationalized market. Read more: […]